These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3930919)

  • 1. Transdermal dosage forms.
    Shaw JE
    Methods Enzymol; 1985; 112():448-61. PubMed ID: 3930919
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route.
    Shaw JE
    Am Heart J; 1984 Jul; 108(1):217-23. PubMed ID: 6428208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of contact dermatitis associated with transdermal therapeutic systems.
    Holdiness MR
    Contact Dermatitis; 1989 Jan; 20(1):3-9. PubMed ID: 2492460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled-release transdermal drug delivery.
    Kelly HW
    Cutis; 1985 Mar; 35(3):204, 207. PubMed ID: 3920010
    [No Abstract]   [Full Text] [Related]  

  • 5. Transdermal therapeutic systems (Part 2).
    Parikh NH; Babar A; Plakogiannis FM
    Pharm Acta Helv; 1985; 60(2):34-8. PubMed ID: 3921987
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic systems--possibilities and limits].
    Meinertz T; Jähnchen E; Just H
    Verh Dtsch Ges Inn Med; 1988; 94():436-41. PubMed ID: 3144813
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17 beta-estradiol: comparison with conventional oral estrogens used for hormone replacement.
    Powers MS; Schenkel L; Darley PE; Good WR; Balestra JC; Place VA
    Am J Obstet Gynecol; 1985 Aug; 152(8):1099-106. PubMed ID: 2992279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal delivery of drugs.
    Brown L; Langer R
    Annu Rev Med; 1988; 39():221-9. PubMed ID: 3130771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Your CE topic (No. 111). Clinical application of transdermal drug delivery systems (Part II).
    Lackner TE
    J Pract Nurs; 1990 Mar; 40(1):42-50. PubMed ID: 2109799
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse dermatologic reactions to transdermal drug delivery systems.
    Hogan DJ; Maibach HI
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):811-4. PubMed ID: 2112162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The promise of transdermal drug delivery.
    Nimmo WS
    Br J Anaesth; 1990 Jan; 64(1):7-10. PubMed ID: 2105738
    [No Abstract]   [Full Text] [Related]  

  • 12. Testing of controlled-release transdermal dosage forms. Product development and clinical trials.
    Shaw JE; Prevo ME; Amkraut AA
    Arch Dermatol; 1987 Nov; 123(11):1548-56. PubMed ID: 2960274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A transdermal therapeutic estradiol system for physiological hormone substitution in the menopause].
    Schenkel L
    Schweiz Rundsch Med Prax; 1985 Mar; 74(11):277-82. PubMed ID: 3887536
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind comparative study of Estraderm and Premarin in the amelioration of postmenopausal symptoms.
    Place VA; Powers M; Darley PE; Schenkel L; Good WR
    Am J Obstet Gynecol; 1985 Aug; 152(8):1092-9. PubMed ID: 2992278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal continuous antihypertensive therapy.
    Weber MA; Drayer JI; Brewer DD; Lipson JL
    Lancet; 1984 Jan; 1(8367):9-11. PubMed ID: 6140393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal drug delivery: a review of pharmaceutics, pharmacokinetics, and pharmacodynamics.
    Moore L; Chien YW
    Crit Rev Ther Drug Carrier Syst; 1988; 4(4):285-349. PubMed ID: 3133121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with rate-controlled delivery of antihypertensive therapy by a transdermal system.
    Weber MA; Drayer JI
    Am Heart J; 1984 Jul; 108(1):231-6. PubMed ID: 6375331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, acceptability, and metabolic effects of transdermal estradiol in the management of postmenopausal women.
    Padwick ML; Endacott J; Whitehead MI
    Am J Obstet Gynecol; 1985 Aug; 152(8):1085-91. PubMed ID: 3927737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcutaneous nitroglycerin--ointment or disc?
    Abrams J
    Am Heart J; 1984 Dec; 108(6):1597-600. PubMed ID: 6439020
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical experience with transdermal estradiol in the treatment of the climacteric.
    Utian WH
    Minerva Endocrinol; 1989; 14(1):45-8. PubMed ID: 2543895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.